Aligned Genetics, Inc. (KOSDAQ:238120)

Market Cap	47.24B
Revenue (ttm)	17.17B
Net Income (ttm)	3.32B
Shares Out	14.06M
EPS (ttm)	232.20
PE Ratio	14.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,240
Average Volume	35,835
Open	3,255.00
Previous Close	3,255.00
Day's Range	3,250.00 - 3,355.00
52-Week Range	2,575.00 - 4,200.00
Beta	0.22
RSI	55.45
Earnings Date	Nov 14, 2025

About Aligned Genetics

Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea.

• Industry: Laboratory Analytical Instruments
• Founded: 2008
• Employees: 66
• Stock Exchange: KOSDAQ
• Ticker Symbol: 238120

Financial Performance

In 2024, Aligned Genetics's revenue was 15.78 billion, an increase of 3.70% compared to the previous year's 15.21 billion. Earnings were 4.13 billion, an increase of 27.57%.